Literature DB >> 7750600

The follicle-stimulating hormone threshold level for follicle maturation in superovulated cycles.

D E Lolis1, O Tsolas, I E Messinis.   

Abstract

OBJECTIVE: To compare the FSH threshold level for follicle growth up to the preovulatory stage between superovulated and natural cycles.
DESIGN: Normally cycling women were investigated during an untreated spontaneous cycle (control) and three cycles treated with FSH.
SETTING: Infertility clinic in a university hospital. PATIENTS: Thirteen normally ovulating women with unexplained infertility.
INTERVENTIONS: Follicle-stimulating hormone was injected at the single dose of six ampules on cycle day 2 without extra FSH (FSH + 0 cycle) or with extra FSH from cycle day 4 onward at the daily dose of either one ampule (FSH + 1 cycle) or two ampules (FSH + 2 cycle). MAIN OUTCOME MEASURES: Serum FSH and E2 during the follicular phase. Number of follicles and growth rate by ultrasound.
RESULTS: Multiple follicular development occurred in all FSH treated cycles. In these cycles the growth rate of the first (dominant) follicle was similar to that in the control cycles. In the presence of physiological concentrations of FSH (control and FSH + 0 cycles), only one follicle was > 15 mm at midcycle. When serum FSH values increased (FSH + 1 and FSH + 2 cycles), the growth rate of the second and third in order follicles and subsequently the number of the preovulatory follicles (> 15 mm) increased in proportion to the FSH increment.
CONCLUSIONS: Follicles recruited by exogenous FSH in the early follicular phase of the cycle require supraphysiological concentrations of FSH throughout the follicular phase to become preovulatory. The extra FSH acts through an increase in the growth rate of these follicles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750600     DOI: 10.1016/s0015-0282(16)57610-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.

Authors:  J Balasch; F Fábregues; M Creus; J Peñarrubia; E Vidal; F Carmona; B Puerto; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  2000-01       Impact factor: 3.412

2.  Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.

Authors:  F J Huang; S Y Chang; M Y Tsai; F T Kung; J F Wu; H W Chang
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

3.  Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.

Authors:  Konstantinos Dafopoulos; Christos Venetis; Christina I Messini; Spyros Pournaras; George Anifandis; Antonios Garas; Ioannis E Messinis
Journal:  Reprod Biol Endocrinol       Date:  2011-04-29       Impact factor: 5.211

4.  Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women.

Authors:  Chao-Chin Hsu; Isabel Hsu; Li-Hsuan Lee; Rosie Hsu; Yuan-Shuo Hsueh; Chih-Ying Lin; Hui Hua Chang
Journal:  Pharmaceutics       Date:  2022-04-15       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.